Financial Highlights:
Stable performance in challenging markets
Reported revenue up 4.1%, down 6.9% at constant currency
Adjusted profit before tax down 3.7%; reflecting lower sales in OI Healthcare and continued weakness in Superconducting Wire
Increase in net debt reflecting working capital outflow and payment of deferred consideration
Interim dividend maintained at 3.7 pence
